Erin A. S. Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erin A. S. Clark has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Michael Walter Varner
University of Utah
6 shared publications - Alan M. Peaceman
Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois
3 shared publications Brian M. Mercer
Department of Obstetrics and Gynecology, MetroHealth Medical Center-Case Western Reserve University, Cleveland, Ohio
3 shared publicationsDwight J. Rouse
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
3 shared publicationsJay D. Iams
Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio
3 shared publications- Steve N. Caritis
Departments of Obstetrics and Gynecology and Reproductive Sciences, Pittsburgh, PA 15213, United States; University of Pittsburgh Schools of Medicine and Pharmacy, Magee-Womens Research Institute, Pittsburgh, PA 15213, United States
3 shared publications
Latest Publications
- Open Access
- 1 July 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (7) , 1515-1524
Performance of a Multianalyte ‘Rule-Out’ Assay in Pregnant Individuals With Suspected Preeclampsia
Background: The ability to diagnose preeclampsia clinically is suboptimal. Our objective was to validate a novel multianalyte assay and characterize its performance, when intended for use as an aid to rule-out preeclampsia. Methods: Prospective, multicenter cohort study of pregnant individuals presenting between 28 0/7 and 36 6/7 weeks’ with preeclampsia-associated signs and symptoms. Individuals not diagnosed with preeclampsia after baseline evaluation were enrolled in the study cohort, with those who later developed preeclampsia, classified as cases and compared with a negative control group who did not develop preeclampsia. Individuals with assay values at time of enrollment ≥0.0325, determined using a previously developed algorithm, considered at risk. The primary analysis was the time to develop preeclampsia assessed using a multivariate Cox regression model. Results: One thousand thirty-six pregnant individuals were enrolled in the study cohort with an incidence of preeclampsia of 30.3% (27.6%–33.2%). The time to develop preeclampsia was shorter for those with an at-risk compared with negative assay result (log-rank P P <0.0001]). The performance metrics for the assay to rule-out preeclampsia within 7 days of enrollment showed a sensitivity 76.4% (67.5%–83.5%), negative predictive value 95.0% (92.8%–96.6%), and negative likelihood ratio 0.46 (0.32–0.65). Assay performance improved if delivery occurred <37 weeks and for individuals enrolled between 28 and 35 weeks. Conclusions: We confirmed that a novel multianalyte assay was associated with the time to develop preeclampsia and has a moderate sensitivity and negative likelihood ratio but high negative predictive value when assessed as an aid to rule out preeclampsia within 7 days of enrollment. Registration: The study was registered on Clinicaltrials.gov (Identifier NCT02780414).
- 1 July 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (7) , 1515-1524
Open AccessPerformance of a Multianalyte ‘Rule-Out’ Assay in Pregnant Individuals With Suspected Preeclampsia
Background: The ability to diagnose preeclampsia clinically is suboptimal. Our objective was to validate a novel multianalyte assay and characterize its performance, when intended for use as an aid to rule-out preeclampsia. Methods: Prospective, multicenter cohort study of pregnant individuals presenting between 28 0/7 and 36 6/7 weeks’ with preeclampsia-associated signs and symptoms. Individuals not diagnosed with preeclampsia after baseline evaluation were enrolled in the study cohort, with those who later developed preeclampsia, classified as cases and compared with a negative control group who did not develop preeclampsia. Individuals with assay values at time of enrollment ≥0.0325, determined using a previously developed algorithm, considered at risk. The primary analysis was the time to develop preeclampsia assessed using a multivariate Cox regression model. Results: One thousand thirty-six pregnant individuals were enrolled in the study cohort with an incidence of preeclampsia of 30.3% (27.6%–33.2%). The time to develop preeclampsia was shorter for those with an at-risk compared with negative assay result (log-rank P P <0.0001]). The performance metrics for the assay to rule-out preeclampsia within 7 days of enrollment showed a sensitivity 76.4% (67.5%–83.5%), negative predictive value 95.0% (92.8%–96.6%), and negative likelihood ratio 0.46 (0.32–0.65). Assay performance improved if delivery occurred <37 weeks and for individuals enrolled between 28 and 35 weeks. Conclusions: We confirmed that a novel multianalyte assay was associated with the time to develop preeclampsia and has a moderate sensitivity and negative likelihood ratio but high negative predictive value when assessed as an aid to rule out preeclampsia within 7 days of enrollment. Registration: The study was registered on Clinicaltrials.gov (Identifier NCT02780414).
- 1 December 2020
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 47 (4) , 671-680
Neonatal and Childhood Outcomes Following Preterm Premature Rupture of Membranes
- 1 December 2020
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 47 (4) , 671-680
Neonatal and Childhood Outcomes Following Preterm Premature Rupture of Membranes
- 6 March 2018
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 35 (10) , 1012-1022
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth
Objective To evaluate the association of magnesium sulfate (MgSO4) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO4 may abrogate this genotype association for some loci. * The members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network are listed in the Appendix.
- 6 March 2018
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 35 (10) , 1012-1022
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth
Objective To evaluate the association of magnesium sulfate (MgSO4) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO4 may abrogate this genotype association for some loci. * The members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network are listed in the Appendix.
- 1 May 2017
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 129 (1) , 2S
Telemedicine to Improve Maternal Safety: A Statewide Survey of Hospitals in an Obstetric Hemorrhage Collaboration [5OP]
Multidisciplinary obstetric hemorrhage patient safety bundles can improve response to hemorrhage and reduce maternal morbidity. Broad dissemination and implementation of these bundles, across institutions and geographic regions, has remained challenging. We implemented a novel, statewide, telemedicine-based education program and evaluated programmatic effect on self-assessed preparedness, prevention, response, and reporting domains within the obstetric hemorrhage patient safety bundle. All Utah hospitals were invited to participate in the Obstetric Hemorrhage Collaborative, an evidence-based educational program aimed at facilitating implementation of the obstetric hemorrhage bundle. The program involved two in-person training meetings and twice-monthly teleconferencing with expert mentorship over 6 months. A statewide self-assessment survey of 38 bundle elements was administered before initiation of the project and after completion. Modified Likert scales were used to describe participant responses. Means and proportions were compared before and after the training. Twenty-seven (61%) of Utah’s obstetric hospitals, representing every hospital system in the state completed the needs-assessment survey. Fifteen (34%) participated in the Obstetric Hemorrhage Collaborative. Hospitals reported implementation, or progress toward implementation, of significantly more elements of the bundle after the educational program compared to before (33.3 vs 19.0, p < 0.001). Hospitals reported increased implementation of elements in all four bundle domains. All participants (100%) reported that teleconferencing sessions were “very helpful,” and 14 (93%) were “very satisfied” with the Collaborative. Utah hospitals report improved implementation of an obstetric hemorrhage bundle as result of a novel educational program using telemedicine. This represents a potentially cost-effective strategy to improve widespread adoption of obstetric hemorrhage bundles.
- 1 May 2017
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 129 (1) , 2S
Telemedicine to Improve Maternal Safety: A Statewide Survey of Hospitals in an Obstetric Hemorrhage Collaboration [5OP]
Multidisciplinary obstetric hemorrhage patient safety bundles can improve response to hemorrhage and reduce maternal morbidity. Broad dissemination and implementation of these bundles, across institutions and geographic regions, has remained challenging. We implemented a novel, statewide, telemedicine-based education program and evaluated programmatic effect on self-assessed preparedness, prevention, response, and reporting domains within the obstetric hemorrhage patient safety bundle. All Utah hospitals were invited to participate in the Obstetric Hemorrhage Collaborative, an evidence-based educational program aimed at facilitating implementation of the obstetric hemorrhage bundle. The program involved two in-person training meetings and twice-monthly teleconferencing with expert mentorship over 6 months. A statewide self-assessment survey of 38 bundle elements was administered before initiation of the project and after completion. Modified Likert scales were used to describe participant responses. Means and proportions were compared before and after the training. Twenty-seven (61%) of Utah’s obstetric hospitals, representing every hospital system in the state completed the needs-assessment survey. Fifteen (34%) participated in the Obstetric Hemorrhage Collaborative. Hospitals reported implementation, or progress toward implementation, of significantly more elements of the bundle after the educational program compared to before (33.3 vs 19.0, p < 0.001). Hospitals reported increased implementation of elements in all four bundle domains. All participants (100%) reported that teleconferencing sessions were “very helpful,” and 14 (93%) were “very satisfied” with the Collaborative. Utah hospitals report improved implementation of an obstetric hemorrhage bundle as result of a novel educational program using telemedicine. This represents a potentially cost-effective strategy to improve widespread adoption of obstetric hemorrhage bundles.
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S295-S296
500: The “night & weekend effect” in obstetrics: truth, or artifact?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S295-S296
500: The “night & weekend effect” in obstetrics: truth, or artifact?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S109
162: Exogenous oxytocin for labor induction or augmentation and autism spectrum disorder
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S109
162: Exogenous oxytocin for labor induction or augmentation and autism spectrum disorder
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S436
751: Predicting need for hysterectomy in puerperal group a strep infection
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S436
751: Predicting need for hysterectomy in puerperal group a strep infection
- 1 August 2016
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 71 (8) , 453-455
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
- 1 August 2016
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 71 (8) , 453-455
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
- Open Access
- 25 November 2013
- Published by F1000 Research Ltd in F1000Research
- Vol. 2
A Genome-Wide Association Study of spontaneous preterm birth in a European population
Background: Preterm birth is defined as a birth prior to 37 completed weeks’ gestation. It affects more than 10% of all births worldwide, and is the leading cause of neonatal mortality in non-anomalous newborns. Even if the preterm newborn survives, there is an increased risk of lifelong morbidity. Despite the magnitude of this public health problem, the etiology of spontaneous preterm birth is not well understood. Previous studies suggest that genetics is an important contributing factor. We therefore employed a genome-wide association approach to explore possible fetal genetic variants that may be associated with spontaneous preterm birth.Methods: We obtained preterm birth phenotype and genotype data from the National Center for Biotechnology Information Genotypes and Phenotypes Database (study accession phs000103.v1.p1). This dataset contains participants collected by the Danish National Birth Cohort and includes 1000 preterm births and 1000 term births as controls. Whole genomes were genotyped on the Illumina Human660W-Quad_v1_A platform, which contains more than 500,000 markers. After data quality control, we performed genome-wide association studies for the 22 autosomal chromosomes.Results: No single nucleotide polymorphism reached genome-wide significance after Bonferroni correction for multiple testing.Conclusion: We found no evidence of genetic association with spontaneous preterm birth in this European population. Approaches that facilitate detection of both common and rare genetic variants, such as evaluation of high-risk pedigrees and genome sequencing, may be more successful in identifying genes associated with spontaneous preterm birth.
- 25 November 2013
- Published by F1000 Research Ltd in F1000Research
- Vol. 2
Open AccessA Genome-Wide Association Study of spontaneous preterm birth in a European population
Background: Preterm birth is defined as a birth prior to 37 completed weeks’ gestation. It affects more than 10% of all births worldwide, and is the leading cause of neonatal mortality in non-anomalous newborns. Even if the preterm newborn survives, there is an increased risk of lifelong morbidity. Despite the magnitude of this public health problem, the etiology of spontaneous preterm birth is not well understood. Previous studies suggest that genetics is an important contributing factor. We therefore employed a genome-wide association approach to explore possible fetal genetic variants that may be associated with spontaneous preterm birth.Methods: We obtained preterm birth phenotype and genotype data from the National Center for Biotechnology Information Genotypes and Phenotypes Database (study accession phs000103.v1.p1). This dataset contains participants collected by the Danish National Birth Cohort and includes 1000 preterm births and 1000 term births as controls. Whole genomes were genotyped on the Illumina Human660W-Quad_v1_A platform, which contains more than 500,000 markers. After data quality control, we performed genome-wide association studies for the 22 autosomal chromosomes.Results: No single nucleotide polymorphism reached genome-wide significance after Bonferroni correction for multiple testing.Conclusion: We found no evidence of genetic association with spontaneous preterm birth in this European population. Approaches that facilitate detection of both common and rare genetic variants, such as evaluation of high-risk pedigrees and genome sequencing, may be more successful in identifying genes associated with spontaneous preterm birth.
- 2 July 2013
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 18 (4) , 858-863
Prevention of Recurrent Preterm Birth: Role of the Neonatal Follow-up Program
- 2 July 2013
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 18 (4) , 858-863
Prevention of Recurrent Preterm Birth: Role of the Neonatal Follow-up Program